China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.31 on Friday. The company has a 50 day moving average of $0.38 and a 200-day moving average of $0.47. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. China Pharma has a 1-year low of $0.30 and a 1-year high of $2.70.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.